| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |